ARCHIVES

Alimta Granted Approval As NSCLC Continuation Therapy

This article is from The Cancer Letter archive.

Vol. 34 No. 11 | November 25, 2011

Download PDF Visit The Full Archive

Related Articles

Increased Lung Cancer Risk After Hodgkin’s Treatment

February 22, 2002

NCAB Opposes Line Item for Centers

May 23, 1980

Agents Not Indicated In Curative Setting.

August 8, 2008

Oncologist Pans Breast Cancer Conference In Russian Heartland

August 19, 1994

Protest Erupts Over Charge That NCAB Directives On CCOP Are Ignored; “Misunderstanding,” DeVita Says

June 25, 1982

In Brief: NCI Still Undecided Over Small Hospital Segment Of CHOP; Multihospital Proposals Review Nov. 14-15

November 2, 1979